The U.S. Food and Drug Administration secretly monitored email communications from 2009 to 2011 for 21 of its employees who were concerned with the agency's medical device review and approval processes, according to an article published this week in the New York Times. The emails were sent to everyone from members of Congress and lawyers to the press and President Obama. The FDA's surveillance efforts stemmed from concerns by scientists that the agency was using "faulty review procedures" to approve medical imaging devices. As a result, according to the Times, patients whose providers used those devices were exposed to dangerous levels of radiation. Article